Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

In vivo and in vitro assessment of hydrogel incorporating Malva sylvestris extract for vulvovaginal candidiasis treatment

Mohammed Sattar Nawrooz1, Asmaa Abdelaziz Mohamed2 , Mohammed Mundher Mhmood3, Hany Akeel Al-hussaniy4

1College of Pharmacy, Ahl al Bayt University,; 2College of Pharmacy, Al-Zahraa University for Women, Karbala, Iraq,; 3Department of Pharmacy, Al-Mansour University College,; 4Department of Pharmacology, College of Pharmacy, Al-Nisour University, Baghdad, Iraq.

For correspondence:-  Asmaa Mohamed   Email: asmaa.abdelaziz@alzahraa.edu.iq   Tel:009647850485328

Received: 22 January 2026        Accepted: 22 July 2026        Published: 31 July 2026

Citation: Nawrooz MS, Mohamed AA, Mhmood MM, Al-hussaniy HA. In vivo and in vitro assessment of hydrogel incorporating Malva sylvestris extract for vulvovaginal candidiasis treatment. Trop J Pharm Res 2026; 25(7):923-929 doi: https://dx.doi.org/10.4314/tjpr.v25i7.3

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To assess the effect of Malva sylvestris (MS) leaf extract incorporated in a hydrogel on vulvovaginal candidiasis. Methods: The plant leaves were extracted with water and characterized phytochemically. Carbopol 940 was employed as the gel base, triethanolamine as a gelling enhancer, and Nipagin (as preservative) was incorporated into ten hydrogel formulations. The prepared formulations were characterized for pH, viscosity, spreadability, and stability. The selected formula (F6) was selected for in vivo assessment of an experimental vulvovaginal candidiasis (VVC) model in three groups of mice, 6 mice each. VVC was induced by intravaginal inoculation, immunosuppressed, and estradiol cypionate was administered subcutaneously to induce the estrus phase. All animals were subsequently inoculated intravaginally. Vaginal load was measured after inoculation to confirm infection at 1, 3, and 6 days as log CFU/mL Results: The pH of the developed formulations ranged from 6.65 to 7.1, viscosities ranged from 6000 to 44,000 cP, and spreadability was 26-48 mm. Formulation F6 (Carbopol 940: polyethylene glycol 400 (PEG 400): propylene glycol: Nipagin M sodium: Nipasol M sodium in ratio 1.2: 10: 10: 0.2: 0.1) was selected due to its appropriate characteristics, as its pH was 6.65, spreadability was 46 mm, and its viscosity was 23000 centipoises. It was also assessed in vivo and proved significantly more effective compared to miconazole at inhibiting C. albicans (p < 0.05). Conclusion: Malva sylvestris incorporated into hydrogel with appropriate excipients demonstrated antifungal activity against vulvovaginal candidiasis with a good physicochemical profile.

Keywords: Antifungal, Candida albicans, Extraction, Hydrogel formation, Malva, Miconazole, VVC

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: